D

Ginkgo Bioworks Holdings
D

DNA

8.04000
USD
0.08
(1.01%)
Market Open
Volume
3,815
EPS
-0
Div Yield
-
P/E
-1
Market Cap
462,130,396
Related Instruments
    A
    A
    -3.140
    (-2.41%)
    127.100 USD
    B
    BGI
    0.02000
    (1.09%)
    1.85000 USD
    C
    C
    0.580
    (0.85%)
    68.730 USD
    D
    D
    1.420
    (2.53%)
    57.610 USD
    X
    X
    -0.670
    (-1.84%)
    35.700 USD
    Z
    Z
    -1.270
    (-1.71%)
    73.030 USD
    More
News

Title: Ginkgo Bioworks Holdings

Sector: Healthcare
Industry: Biotechnology
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.